Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Devicor developed and commercialized minimally invasive breast biopsy devices and related diagnostic tools. Its flagship products include the Mammotome vacuum-assisted breast biopsy systems, Neoprobe Gamma Detection System for sentinel lymph node mapping, specimen radiography systems, and a comprehensive portfolio of tissue markers. These technologies are widely used globally for accurate diagnosis of breast cancer and have enabled millions of procedures with improved patient outcomes.[1][2][3] The company has been fully integrated into Leica Biosystems since its acquisition in December 2014.[2]
No clinical trial results are applicable as these are FDA-cleared diagnostic devices rather than therapeutics.Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Devicor Medical Products.